In 2023, natural gas consumption in the manufacture of medicines in China stood at 34.90 hundred million cubic meters. The forecasted data indicate a continuous increase in natural gas consumption from 39.64 in 2024 to 58.89 in 2028. This signifies a year-on-year growth ranging between 12% to 11%, suggesting a robust upward trend driven by rising pharmaceutical manufacturing requirements. Over the five-year period from 2024 to 2028, the compound annual growth rate (CAGR) is projected at approximately 10.1%, underlining strong expansion in demand.
Future trends to watch for include advancements in pharmaceutical technologies that could drive further consumption, regulatory policies impacting energy use, and shifts in energy efficiency practices within the sector, which may alter future natural gas demands.
